Phenotypic presentation of the Ser63Del MPZ mutation

Area of Science:

• Neurogenetics
• Molecular Neurology
• Cellular Biology

Background:

• Mutations in the myelin protein zero (MPZ) gene are a significant cause of Charcot-Marie-Tooth disease type 1B (CMT1B).
• Previous research in mouse models indicated that the Ser63del MPZ mutation leads to endoplasmic reticulum (ER) retention and activation of the unfolded protein response (UPR), contributing to neuropathy.
• Clinical data on patients with the Ser63del MPZ mutation were previously limited.

Observation:

• This study presents clinical and electrophysiological data from a large, multigenerational family with CMT1B caused by the Ser63del MPZ mutation.
• Patients with the Ser63del MPZ mutation exhibited a classical CMT1 phenotype.
• The observed phenotype in Ser63del MPZ patients was notably less severe compared to patients with the Arg98Cys MPZ mutation, which also activates the UPR.

Findings:

• The Ser63del MPZ mutation results in a classical CMT1 phenotype.
• The clinical severity of CMT1B associated with Ser63del MPZ is significantly less than that observed with Arg98Cys MPZ.
• Both Ser63del and Arg98Cys MPZ mutations activate the unfolded protein response (UPR).

Implications:

• Clinical presentation alone is insufficient to predict whether specific MPZ mutations will be retained in the ER and activate the UPR.
• Understanding the varying clinical severity associated with different MPZ mutations, even those activating the UPR, is crucial for predicting disease progression.
• Further research is needed to elucidate the molecular mechanisms underlying the differential severity of MPZ-related neuropathies.